Skip to main content
. 2022 Jun 21;9:936926. doi: 10.3389/fnut.2022.936926

Table 2.

Results of the univariate logistic regression analysis of factors associated with nonfatal cardiovascular/cerebrovascular events, weighted.

Statistics OR (95%CI)
Age (years) 47.64 ± 0.39 1.08 (1.07, 1.09)
Sex, n (%)
Male (n = 4,370) 48.43 Ref
Female (n = 4,502) 51.57 0.71 (0.56, 0.90)
Race, n (%)
Mexican American (n = 1,129) 7.79 Ref
Other races (n = 2,248) 14.02 1.50 (1.01, 2.23)
Non-hispanic White (n = 3,545) 67.81 1.71 (1.19, 2.47)
Non-hispanic Black (n = 1,950) 10.38 2.01 (1.44, 2.81)
Marital status, n (%)
Married/Living with partner (n = 5,228) 63.67 Ref
Widowed/divorced/separated (n = 1,936) 18.18 1.95 (1.54, 2.47)
Never married (n = 1,708) 18.16 0.44 (0.30, 0.64)
Educational level, n (%)
< High school (n = 1,738) 12.56 Ref
High school (n = 1,944) 21.72 0.88 (0.65, 1.19)
>High school (n = 5,190) 65.72 0.45 (0.33, 0.60)
PIR, n (%)
<1.2 (n = 2,442) 18.51 Ref
≥1.2 (n = 6,430) 81.49 0.72 (0.57, 0.91)
Bady mass index, n (%)
<25 kg/m2 (n = 2,554) 28.54 Ref
25 to 30 kg/m2 (n = 2,874) 32.91 1.28 (0.95, 1.72)
≥30 kg/m2 (n = 3,444) 38.56 1.89 (1.41, 2.53)
Current smoker, n (%)
Yes (n = 546) 6.09 Ref
No (n = 583) 7.11 1.32 (0.66, 2.65)
Unknown (n = 7,743) 86.80 0.86 (0.52, 1.40)
Systolic blood pressure (mmHg) 122.07 ± 0.27 1.02 (1.01, 1.03)
Diastolic blood pressure (mmHg) 70.67 ± 0.30 0.98 (0.97, 0.99)
Glucose (mg/dl) 99.55 ± 0.48 1.01 (1.01, 1.01)
Cholesterol (mg/dl) 192.58 ± 0.69 0.99 (0.99, 0.99)
Triglycerides (mg/dl) 149.32 ± 2.28 1.00 (1.00, 1.00)
HDL (mg/dl) 54.12 ± 0.35 0.99 (0.98, 1.00)
Glycohemoglobin (%) 5.63 ± 0.02 1.45 (1.36, 1.55)
Energy intake (kcal/day) 2,182.17 ± 10.89 1.00 (1.00, 1.00)
Vigorous activity, n (%)
Yes (n = 1,840) 22.98 Ref
No (n = 7,032) 77.02 1.42 (1.03, 1.97)
Diabetes, n (%)
Yes (n = 1,143) 9.49 Ref
No (n = 7,499) 88.13 0.20 (0.15, 0.26)
Borderline (n = 230) 2.38 0.62 (0.35, 1.09)
Hypertension, n (%)
Yes (n = 3,228) 32.44 Ref
No (n = 5,644) 67.56 0.19 (0.15, 0.24)
Hypercholesteremia, n (%)
Yes (n = 3,107) 34.32 Ref
No (n = 5,765) 65.68 0.23 (0.18, 0.30)
Sleeping disorder, n (%)
Yes (n = 2,403) 29.77 Ref
No (n = 6,469) 70.23 0.57 (0.46, 0.71)
Hypoglycemic drugs, n (%)
Yes (n = 874) 7.44 Ref
No (n = 1,125) 11.52 0.65 (0.45, 0.93)
Unknown (n = 6,873) 81.04 0.21 (0.15, 0.28)
Antihypertensive drugs, n (%)
Yes (n = 2,426) 23.44 Ref
No (n = 396) 4.43 0.41 (0.23, 0.71)
Unknown (n = 6,050) 72.13 0.16 (0.12, 0.20)
Lipid-lowing drugs, n (%)
Yes (n = 1,749) 18.27 Ref
No (n = 584) 6.01 0.32 (0.21, 0.50)
Unknown (n = 6,539) 75.72 0.11 (0.09, 0.14)
Preventive aspirin use, n (%)
Yes (n = 190) 2.66 Ref
No (3,437) 39.08 1.08 (0.33, 3.57)
Unknown (n = 5,245) 58.26 3.39 (1.08, 10.65)
Fiber intake (g/day) 17.38 ± 0.22 0.98 (0.97, 0.99)
Fiber intake tertile, n (%)
Tertile1 (n = 2,929) 30.88 Ref
Tertile2 (n = 2,959) 34.82 0.83 (0.66, 1.04)
Tertile3 (n = 2,984) 34.29 0.64 (0.48, 0.84)

Mean ± standard error (SE) for continuous variables, Percentage (%) for categorical variables. p-Value was calculated via logistic regression analysis.

Tertile1, 7.51 ± 0.07 g/day; Tertile2, 14.90 ± 0.05 g/day; Tertile3, 28.79 ± 0.25 g/day.

OR, odds ration; 95% CI, 95% confidence interval; PIR, poverty to income ratio; BMI, body mass index; HDL, high density lipoprotein.